- Home
- BKE vs APLS Comparison
BKE vs APLS Comparison
Compare BKE & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKE | APLS |
|---|---|---|
| Founded | 1948 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BKE | APLS |
|---|---|---|
| Price | $49.36 | $17.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 21 |
| Target Price | ★ $53.00 | $31.65 |
| AVG Volume (30 Days) | 380.4K | ★ 1.9M |
| Earning Date | 03-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 8.86% | N/A |
| EPS Growth | N/A | ★ 112.50 |
| EPS | ★ 2.55 | 0.20 |
| Revenue | ★ $1,217,689,000.00 | $1,003,782,000.00 |
| Revenue This Year | $4.25 | N/A |
| Revenue Next Year | $5.84 | $18.21 |
| P/E Ratio | ★ $19.48 | $88.20 |
| Revenue Growth | N/A | ★ 28.46 |
| 52 Week Low | $33.12 | $16.10 |
| 52 Week High | $61.69 | $30.48 |
Technical Indicators
Market Signals| Indicator | BKE | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 29.14 |
| Support Level | $47.83 | N/A |
| Resistance Level | $50.31 | $20.65 |
| Average True Range (ATR) | 1.48 | 0.66 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 22.51 | 5.12 |
Price Performance
Historical ComparisonAbout BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.